Adam D'AugelliSan Francisco, California, United States, United States
I work for True Ventures, an early-stage venture capital fund with offices in San Francisco and Palo Alto. We partner with promising entrepreneurs at the earliest stages in the technology market providing hands-on management support to guide our portfolio companies through the challenges of early growth.
Jun 2010 - Current
Founded in 2005, True Ventures is a Silicon Valley-based venture capital firm that invests in early-stage technology startups. With $2.8 billion under management, True provides pre-seed, seed, and early Series A funding to the most talented entrepreneurs in today’s fastest growing markets. Led True's investments in Splice, Namely, Ginger, Pendulum Therapeutics, Deep Genomics, Feelmore Labs, Riva Health, Prime Roots, Flipside Crypto, Ampleforth, Forta Network, Chia Network, Serenity Bioworks, InterVenn Biosciences, Filtricine, Our Kettle, Fork N Goode, and others currently in stealth Prior investments include: HashiCorp (NASDAQ: HCP), TripleLift (Acquired by Vista Equity), Ring (Acquired by Amazon), Runscope (Acquired by CA Technologies), Moleculo (Acquired by Illumina)
University of Florida
Dec 2007 - May 2010
From the Spring of 2007 until the Spring of 2010, I was a Teacher's Assistant for Introduction to Business Finance (FIN 3403) under Professor T. Craig Tapley. In the Spring of 2010, I developed the curriculum for and taught Digital Frontiers (IDH 3931), which discussed how the Internet and globalization are affecting the business world. The course was built around a series of guest lectures by speakers from local venture-backed startups and case studies developed by the students in groups.
University of Florida - Warrington College Of BusinessMaster of Science, Finance
University of Florida - Warrington College Of BusinessBachelor of Science in Business Administration, Finance